iTeos Therapeutics, Inc. - COM (ITOS)

Historical Portfolio Holders from Q3 2020 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
36.1M
Holdings value Q2 2024
$536M
Value change Q2 2024
+$26.2M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
131
Number of buys Q2 2024
71
Number of sells Q2 2024
-60
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 12.4K $126K +$126K $10.20 1
2024 Q2 36.1M $536M +$26.2M $14.84 131
2024 Q1 34.5M $471M -$29K $13.64 127
2023 Q4 35M $383M -$6.01M $10.95 130
2023 Q3 35.5M $389M +$7.23M $10.95 141
2023 Q2 34.5M $457M -$20.4M $13.24 140
2023 Q1 36M $489M -$5.82M $13.61 149
2022 Q4 36.2M $707M -$15.8M $19.53 144
2022 Q3 36.6M $698M -$16.3M $19.05 133
2022 Q2 37.3M $768M +$2.33M $20.60 149
2022 Q1 36M $1.16B +$80.8M $32.18 154
2021 Q4 33.4M $1.55B +$105M $46.56 115
2021 Q3 31.2M $841M +$47.3M $27.00 76
2021 Q2 29.5M $756M -$27.4M $25.65 82
2021 Q1 30.1M $1.03B +$89.1M $34.18 78
2020 Q4 29.3M $987M +$60.5M $33.82 72
2020 Q3 25M $614M +$614M $24.67 54